In: Cellular & molecular immunology, 2021, p. 19
Autoimmune hepatitis (AIH) is a T-cell mediated, inflammatory liver disease affecting all ages and characterized by female preponderance, elevated serum transaminase and immunoglobulin G levels, positive circulating autoantibodies, and presence of interface hepatitis at liver histology. AIH type 1, affecting both adults and children, is defined by positive anti- nuclear and/or antismooth muscle...
|
In: Clinical reviews in allergy & immunology, 2021, p. 14
Circulating autoantibodies are a key diagnostic tool in autoimmune hepatitis (AIH), being positive in 95% of the cases if tested according to dedicated guidelines issued by the International Autoimmune Hepatitis Group. They also allow the distinction between type 1 AIH, characterized by positive anti-nuclear and/or anti-smooth muscle antibody, and type 2 AIH, characterized by positive...
|
In: International journal of environmental research and public health, 2021, vol. 18, no. 10, p. 24
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver disease in the Western world, probably due to the growing prevalence of obesity, metabolic diseases, and exposure to some environmental agents. In certain patients, simple hepatic steatosis can progress to non-alcoholic steatohepatitis (NASH), which can sometimes lead to liver cirrhosis and its...
|
In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 9, p. 2540-2545
|
In: Clinical Chemistry and Laboratory Medicine (CCLM), 2017, vol. 55, no. 9, p. 1407-1416
|
In: Archives of Toxicology, 2015, vol. 89, no. 6, p. 851-865
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1755-1758
|
In: American Journal of Epidemiology, 2018, vol. 187, no. 8, p. 1714-1720
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 9, p. 2574-2577
|
In: Journal of Infectious Diseases, ///-
|